Download PDF
Int J Angiol 2021; 30(04): 257-261
DOI: 10.1055/s-0041-1726468
Original Article

Relationship between Mean Platelet Volume and Critical Limb Ischemia in Diabetes Mellitus Patients

Muhammad Berian Rachmanadi
1   Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
,
Muhamad Taufik Ismail
2   Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito Hospital, Yogyakarta, Indonesia
,
Vita Yanti Anggraeni
2   Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Dr. Sardjito Hospital, Yogyakarta, Indonesia
› Author Affiliations Funding There is no financial relationship or competing interests regarding the content of this article.
› Further Information
    Permissions and Reprints

Abstract

The prevalence of diabetes mellitus continues to increase from year to year. Critical limb ischemia (CLI) is one of the complications of diabetes mellitus with a high mortality rate and requires amputation if not treated properly. Mean platelet volume (MPV) is an indicator of platelet activation and is expected to be a predictor of CLI in diabetes mellitus patients.

This article investigates the relationship between MPV and the incidence of CLI in diabetes mellitus patients.

This case–control study was conducted using the vascular registry of Dr. Sardjito Hospital, Yogyakarta, Indonesia, from January 2016 to December 2016. The relationship between MPV and the incidence of CLI was analyzed using bivariate and multivariate analysis.

There was a significant association between MPV and incidence of CLI in diabetes mellitus patient both on bivariate analysis (p = 0.035) and multivariate analysis (p = 0.029). Diabetes mellitus patients with MPV values of ≥ 9.8 fl had a protective effect to prevent the incidence of CLI (bivariate analysis: odds ratio [OR] = 0.366, 95% confidence interval [CI] = 0.142–0.943; multivariate analysis: adjusted OR = 0.288, 95% CI = 0.09–0.88). Confounding factors such as sex, age, obesity, and use of antiplatelet agents were not associated with the incidence of CLI (p > 0.05). Meanwhile, history of dyslipidemia as a confounding factor was significantly associated with the incidence of CLI (p < 0.05).

Low MPV was found to be significantly associated with the incidence of CLI in diabetes mellitus patients.

Keywords

diabetes mellitus - critical limb ischemia - mean platelet volume - case–control


Publication History

Article published online:
20 April 2021

© 2021. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 IDF. IDF Diabetes Atlas. 7th ed.. 2015. DOI: 10.1289/image.ehp.v119.i03
    CrossrefGoogle Scholar
  • 2 Heart.org. About Peripheral Artery Disease (PAD). American Heart Association. 2016 . Accessed February 4, 2017 at: http://www.heart.org/HEARTORG/Conditions/VascularHealth/PeripheralArteryDisease/About-Peripheral-Artery-Disease-PAD_UCM_301301_Article.jsp#.WMwLKTt97Dc.
    PubMedGoogle Scholar
  • 3 Varu VN, Hogg ME, Kibbe MR. Critical limb ischemia. J Vasc Surg 2010; 51 (01) 230-241
    CrossrefPubMedGoogle Scholar
  • 4 Bowers BL, Valentine RJ, Myers SI, Chervu A, Clagett GP. The natural history of patients with claudication with toe pressures of 40 mm Hg or less. J Vasc Surg 1993; 18 (03) 506-511
    CrossrefPubMedGoogle Scholar
  • 5 Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997; 2 (03) 221-226
    CrossrefPubMedGoogle Scholar
  • 6 Dormandy JA, Murray GD. Reprinted article “The fate of the claudicant--a prospective study of 1969 claudicants”. Eur J Vasc Endovasc Surg 2011; 42 (Suppl. 01) S4-S6
    CrossrefPubMedGoogle Scholar
  • 7 Dormandy JA, Thomas P. What is the natural history of a critically ischemic patient with and without his leg?. In: Greenhalgh R, Jamieson C, Nicolaides A. eds. Limb Salvage and Amputation for Vascular Disease. London: WB Saunders; 1988: 11-26
    Google Scholar
  • 8 Hirsch AT, Haskal ZJ, Hertzer NR. et al; American Association for Vascular Surgery, Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease, American Association of Cardiovascular and Pulmonary Rehabilitation, National Heart, Lung, and Blood Institute, Society for Vascular Nursing, TransAtlantic Inter-Society Consensus, Vascular Disease Foundation. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113 (11) e463-e654
    CrossrefPubMedGoogle Scholar
  • 9 Burger H, Maricek C. Disability and rehabilitation: return to work after lower limb amputation. Disabil Rehabil 2007; 29 (17) 1323-1329
    CrossrefPubMedGoogle Scholar
  • 10 Teraa M, Conte MS, Moll FL, Verhaar MC. Critical limb ischemia: current trends and future directions. J Am Heart Assoc 2016; 5 (02) 9
    CrossrefPubMedGoogle Scholar
  • 11 Chu SG, Becker RC, Berger PB. et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010; 8 (01) 148-156
    CrossrefPubMedGoogle Scholar
  • 12 Lilly LS. ed. Pathophysiology of Heart Disease. 5th ed.. Philadelphia: Lippincott Williams & Wilkins; 2011
    Google Scholar
  • 13 Rief P, Raggam RB, Avian A. et al. Low mean platelet volume is associated with critical limb ischemia in peripheral arterial occlusive disease. Sci Rep 2018; 8 (01) 6718
    CrossrefPubMedGoogle Scholar
  • 14 Ranjith MP, DivyaRaj R, Mathew D, George B, Krishnan MN. Mean platelet volume and cardiovascular outcomes in acute myocardial infarction. Heart Asia 2016; 8 (01) 16-20
    CrossrefPubMedGoogle Scholar
  • 15 Degerli V, Ergin I, Duran FY, Ustuner MA, Duran O. Could mean platelet volume be a reliable indicator for acute mesenteric ischemia diagnosis? A case-control study. BioMed Res Int 2016; 2016: 9810280
    CrossrefPubMedGoogle Scholar
  • 16 Arican Ozluk O, Ber I, Peker T. et al. Mean platelet volume levels in the presence of angiographically documented peripheral artery disease. Int J Clin Exp Med 2015; 8 (02) 2899-2904
    PubMedGoogle Scholar
  • 17 Suades R, Padró T, Vilahur G, Badimon L. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb Haemost 2012; 108 (06) 1208-1219
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Li S, Wei J, Zhang C. et al. Cell-derived microparticles in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Cell Physiol Biochem 2016; 39 (06) 2439-2450
    CrossrefPubMedGoogle Scholar
  • 19 Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complications 2009; 23 (02) 89-94
    CrossrefPubMedGoogle Scholar
  • 20 Ferroni P, Basili S, Davi G. Platelet activation, inflammatory mediators and hypercholesterolemia. Curr Vasc Pharmacol 2003; 1 (02) 157-169
    CrossrefPubMedGoogle Scholar
  • 21 Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation?. Curr Pharm Des 2011; 17 (01) 47-58
    CrossrefPubMedGoogle Scholar